Skip to main content

Table 1 Demographics

From: Quality of life and functional outcome after infravesical desobstruction and HIFU treatment for localized prostate cancer

 

n (%)

mean (SD)

Age (years)

131

72.8 (6.0)

Clinical stage

 cT1

83 (63.8%)

 

  ≥ cT2

47 (36.2%)

 

Gleason Score

  ≤ 6

57 (43.5%)

 

 7

66 (50.4%)

 

  ≥ 8

8 (6.1%)

 

inital PSA (ng/ml)

130

9.6 (14.9)

Risk stratification (D’Amico)

 Low - risk

38 (29.0%)

 

 Intermediate - risk

77 (58.8%)

 

 High - risk

16 (12.2%)

 

Prostate volume (ml)

130

43.7 (25.6)

Prostate volume after resection

123

26.0 (12.5)